| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/13/2005 | US6942981 Method of determining interactions with PDZ-domain polypeptides |
| 09/13/2005 | US6942979 Method for screening substances capable of modulating the activity of a TRAAK potassium channel |
| 09/13/2005 | US6942978 Diagnosing cancer by detecting a TADG-12 protein in biological sample, immunoaffinity to an antibody, bioassay, immunoassay |
| 09/13/2005 | US6942976 Detection of plant nucleotide sequences in sample; obtain sample containing target nucleotide sequences, incubate with primers, amplify, recover product, clone, transform cell, propagate, sequence and compare insert to control |
| 09/13/2005 | US6942965 Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof |
| 09/13/2005 | US6942866 Hepatitis viral protein for use in treatment of viral diseases |
| 09/13/2005 | US6942865 Methods and reagents to detect and characterize norwalk and related viruses |
| 09/13/2005 | US6942863 Polypeptide for use the prevention of infections associated with tissue grafting |
| 09/13/2005 | US6942862 Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins |
| 09/13/2005 | US6942861 Functional bacterial protein, intimin, and its use as an antigen for protecting against infection by or transmission of bacteria expressing intimin-like proteins, such as certain pathogenic strains of Escherichial coli |
| 09/13/2005 | US6942854 Orally-administered interferon-tau compositions and methods |
| 09/13/2005 | US6942853 Latent fusion protein |
| 09/13/2005 | US6942852 N-terminal modifications of RANTES and methods of use |
| 09/13/2005 | US6942802 Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography |
| 09/13/2005 | CA2426703C Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 09/13/2005 | CA2261930C Frozen confectionery products |
| 09/13/2005 | CA2213991C Cold-inducible promoter sequence |
| 09/13/2005 | CA2175476C Opioid receptor: compositions and methods |
| 09/13/2005 | CA2106315C Gene construct for production of transgenic fish |
| 09/09/2005 | WO2005083444A1 Protein phosphorylation in t-cell receptor signaling pathways |
| 09/09/2005 | WO2005083442A1 Methods for screening insecticides |
| 09/09/2005 | WO2005083439A1 Protein phosphorylation in anaplastic large cell lymphoma |
| 09/09/2005 | WO2005083431A2 Binding agents |
| 09/09/2005 | WO2005083126A2 Alterations of fibulin genes in macular degeneration |
| 09/09/2005 | WO2005083113A1 Protein phosphorylation in c-src signaling pathways |
| 09/09/2005 | WO2005083098A1 Recombinant perforin, expression and uses thereof |
| 09/09/2005 | WO2005083092A2 Transposon from aspergillus fumatigus and mutagenesis therewith |
| 09/09/2005 | WO2005083088A1 E.coli o157:h7 c1 esterase inhibitor-binding protein stce and uses thereof |
| 09/09/2005 | WO2005083082A1 Method for producing l-amino acids by means of recombinant coryneform bacteria with reduced activity asur regulators |
| 09/09/2005 | WO2005083075A1 Novel gene participating in epidermal differentiation and use thereof |
| 09/09/2005 | WO2005083074A1 Tumor antigen peptides |
| 09/09/2005 | WO2005083072A1 Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli |
| 09/09/2005 | WO2005083070A1 Pharmaceutical composition for lowering blood sugar level |
| 09/09/2005 | WO2005083068A2 Methods for obtaining thermostable enzymes, dna polymerase i variants from thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications to the same |
| 09/09/2005 | WO2005083058A1 Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells |
| 09/09/2005 | WO2005082941A1 Bone sialoprotein collagen-binding peptides |
| 09/09/2005 | WO2005082936A1 Means for a quantitative detection of cytochrome c |
| 09/09/2005 | WO2005082935A1 Stamp modulation of glucocorticoid-responsive gene expression |
| 09/09/2005 | WO2005082934A2 Novel apo2l and il-24 polypeptides, polynucleotides, and methods of their use |
| 09/09/2005 | WO2005082933A1 Novel chimeric protein, gene encoding the same, and means of judging leukemia using the gene and the protein |
| 09/09/2005 | WO2005082932A2 Compositions and methods using rna interference for control of nematodes in plants |
| 09/09/2005 | WO2005082931A1 Novel phytochrome-interacting protein and a use thereof |
| 09/09/2005 | WO2005082930A2 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof |
| 09/09/2005 | WO2005082929A2 Beak and feather disease virus sequences, compositions and vaccines and the use thereof in therapy, diagnosis and assays |
| 09/09/2005 | WO2005082928A2 Peptide analogues of gip for treatment of diabetes, insulin resistance and obesity |
| 09/09/2005 | WO2005082927A2 Antihypertensive peptides |
| 09/09/2005 | WO2005082894A1 Cell targeting conjugates |
| 09/09/2005 | WO2005082396A2 Use of mda-7 to inhibit infection by pathogenic organisms |
| 09/09/2005 | WO2005082137A1 Mammal for studying dcis and the effect of inactivated tumor suppressors |
| 09/09/2005 | WO2005082077A2 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 09/09/2005 | WO2005082076A2 Methods for treating breast cancer using nrif3 related molecules |
| 09/09/2005 | WO2005082020A2 Flavivirus vaccines |
| 09/09/2005 | WO2005082008A2 Methods for diagnosing and treating bladder cancer |
| 09/09/2005 | WO2005081873A2 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 09/09/2005 | WO2005081872A2 Methods and compositions comprising supramolecular constructs |
| 09/09/2005 | WO2005081858A2 Parkin-associated complex for protecting post-mitotic neurons from excitotoxicity and uses thereof |
| 09/09/2005 | WO2005081854A2 Egf receptor epitope peptides and uses thereof |
| 09/09/2005 | WO2005081783A2 Method for determination and quantification of radiation or genotoxin exposure |
| 09/09/2005 | WO2005081743A2 Membrane scaffold proteins |
| 09/09/2005 | WO2005072223A3 Engineered proteins, and methods of making and using |
| 09/09/2005 | WO2005065722A3 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
| 09/09/2005 | WO2005063991A3 Live genetically attenuated malaria vaccine |
| 09/09/2005 | WO2005062947A3 Methods and compositions for identifying rna-binding proteins |
| 09/09/2005 | WO2005060997A3 Medicament comprising inhibitors of long pentraxin ptx3 |
| 09/09/2005 | WO2005058957A3 Ztnf 12, a tumor necrosis factor |
| 09/09/2005 | WO2005056036A3 Regulation of food preference using glp-1 agonists |
| 09/09/2005 | WO2005054275A3 Nanofiltration of factor vii solutions to remove virus |
| 09/09/2005 | WO2005051994A3 Ztnf11, a tumor necrosis factor |
| 09/09/2005 | WO2005049853A3 Compositions and methods for screening pro-apoptotic compounds |
| 09/09/2005 | WO2005049841B1 Insect resistance using inhibition of gene expression |
| 09/09/2005 | WO2005047483A3 Renta: an hiv immunogen and uses thereof |
| 09/09/2005 | WO2005047481A3 Novel sequences encoding hapatitis c virus glycoproteins |
| 09/09/2005 | WO2005046708A8 Selective inhibitors of nuclear factor-kb activation and uses thereof |
| 09/09/2005 | WO2005044996A3 Chimeric receptors with 4-1bb stimulatory signaling domain |
| 09/09/2005 | WO2005034992A3 Hiv vaccines based on env of multiple clades of hif |
| 09/09/2005 | WO2005034733A3 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
| 09/09/2005 | WO2005033265A3 Optimized multi-epitope constructs and uses thereof |
| 09/09/2005 | WO2005030802A3 Antigens for an east coast fever vaccine |
| 09/09/2005 | WO2005030797A3 Melanocortin receptor agonists |
| 09/09/2005 | WO2005026362A3 Lymphatic and blood endothelial cell genes |
| 09/09/2005 | WO2005026359A3 The use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases |
| 09/09/2005 | WO2005014623A3 Compounds comprising lpa |
| 09/09/2005 | WO2005012330A3 AMYLOID β-PEPTIDE AND METHODS OF USE |
| 09/09/2005 | WO2005009287A3 Drug delivery to the inner ear and methods of using same |
| 09/09/2005 | WO2005007804A3 Anthrax conjugate vaccine and antibodies |
| 09/09/2005 | WO2005002526A3 Method and compositions for treatment of viral infections |
| 09/09/2005 | WO2005002325A3 Generation of plants with improved drought tolerance |
| 09/09/2005 | WO2005000882A3 Dna fragments and proteins encoded by said dna isolated from bifidobacteria |
| 09/09/2005 | WO2005000220A8 Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes |
| 09/09/2005 | WO2005000198A3 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same |
| 09/09/2005 | WO2004113513A3 Methods and compositions for modulating stem cell growth and differentiation |
| 09/09/2005 | WO2004112691A3 Interferon gamma therapies for idiopathic pulmonary fibrosis |
| 09/09/2005 | WO2004111090A3 Molecules for targeting and releasing therapeutic compounds, and the use thereof |
| 09/09/2005 | WO2004076635A3 Therapeutic applications of thrombomodulin gene via viral and non-viral vectors |
| 09/09/2005 | WO2004061113A8 Adeno-associated virus mediated b7.1 vaccination synergizes with angiostatin to eradicate disseminated liver metastatic cancers |
| 09/09/2005 | WO2004054433A3 Forming iron nitrosyl hemoglobin |
| 09/09/2005 | WO2004046169A8 Activation of peptide prodrugs by hk2 |
| 09/09/2005 | WO2004044176A8 Adenoviral vector vaccine |
| 09/09/2005 | WO2003084477A3 Mammalian cdr mimetibodies, compositions, methods and uses |
| 09/09/2005 | WO2003057854A3 Novel proteins and nucleic acids encoding same |